Desjardins Global Asset Management Inc. Royalty Pharma PLC Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 2,266 shares of RPRX stock, worth $60,660. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,266
Previous 2,235
1.39%
Holding current value
$60,660
Previous $60,000
5.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
393Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.18 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$568 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$446 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$307 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...